Measures to deal with the anemia were: expectancy (n = 15); RIBA dose reduction only (n = 12); RIBA dose reduction, erythropoietin treatment, and blood transfusions (n = 4); RIBA dose reduction and blood transfusions (n = 3); and RIBA dose reduction, erythropoietin treatment (n = 1). The gene discussed is EPO; the disease is anemia (phenotype).